Search

everythinglearnresearchcommunity

for

Search:↓

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Most Facebook posts about hair loss treatments are promotional and not medically supported, with better quality information found on YouTube.

Tetracycline can stick to hair follicles and potentially cause hair loss.

PCOS women with COVID-19 have higher cardiometabolic risks.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

Balancing testosterone may reduce COVID-19 severity.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Men had worse COVID-19 outcomes than women in New York City.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Systemic retinoids do not increase COVID-19 risk or severity.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

New-onset fibromyalgia after COVID-19 is poorly understood, needing better definitions and studies.

Survivors of severe COVID-19 need ongoing care to manage lasting health issues.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

During the COVID-19 pandemic, dermatology visits decreased, especially among older patients, patients of color, men, and those with chronic conditions.

Androgens may worsen COVID-19 severity in men.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The pandemic caused new skin problems in children, mainly due to mask-wearing and stress.